Other languages SOPHiA GENETICS SA

Equities

SOPH

CH1125843347

Market Closed - Nasdaq Other stock markets 04:30:01 2024-04-25 pm EDT			5-day change	1st Jan Change
4.95 ^USD	-2.17%		+3.12%	+5.10%

Apr. 23	Sophia Genetics Says Nigeria's Syndicate Bio Signs on to Implement Liquid Biopsy Offering	MT
Apr. 23	SOPHiA GENETICS Announces Syndicate Bio as First Liquid Biopsy Customer in Africa	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

SOPHiA GENETICS Announces Syndicate Bio as First Liquid Biopsy Customer in Africa	Apr. 23
SOPHiA GENETICS Announces Unilabs Using Its AI Technology to Detect Homologous Recombination Deficiency	Apr. 17
Sophia Genetics SA Announces Laboratorio Barnafi-Krause Is Live on the Sophia DDM? Platform	Apr. 02
SOPHiA GENETICS Announces First Homologous Recombination Deficiency Customer in Canada	Mar. 20
SOPHiA GENETICS SA Provides Earnings Guidance for 2024	Mar. 05
SOPHiA GENETICS SA Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Mar. 05
Un triumvirat à la tête de Swisscom Ventures	Feb. 15
Sophia Genetics, AstraZeneca Expand Project to Improve Access to Ovarian Cancer Testing in Spain	Feb. 07
SOPHiA GENETICS and AstraZeneca Spain Commit to Increasing Ovarian Cancer Testing in Spain	Feb. 07
Sophia Genetics Supports Genetic Testing in Brazil	Jan. 25
SOPHiA GENETICS Enhances RareCyte Inc. Precision Biology Services Portfolio	Jan. 18
SOPHiA GENETICS and Karkinos Healthcare Forge Strategic Partnership to Advance Cancer Research in India	Jan. 14
SOPHiA GENETICS SA Provides Preliminary Earnings Guidance for the Full Year Ending December 31, 2023	Jan. 10
Exactis Innovation and SOPHiA GENETICS Announce Collaboration on Multimodal Data Analytics	Jan. 08
SOPHiA GENETICS SA Announces Expanded Suite of Liquid Biopsy Offerings	Dec. 07
Sophia Genetics Says CHU de Nimes Uses DDM Platform for Pharmacogenomics Research	Nov. 30
Sophia Genetics Announces Expansion of Work with Chu De Nîmes	Nov. 30
SOPHiA GENETICS Expands Relationship with Citta della Salute e della Scienza di Torino	Nov. 28
Las mejores acciones para ganar en bolsa en Wall Street en 2024	Nov. 20
BioReference® Signs On as the First Laboratory to Use MSK-ACCESS® Powered with SOPHiA DDM?	Nov. 07

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages SOPHiA GENETICS SA

Equities

SOPH

CH1125843347

Other languages

Filters